UTILISATION D'ANTAGONISTES D'IL-20 POUR LE TRAITEMENT DE MALADIES HÉPATIQUES

• 收藏
• 分享

专利权人:

CHANG, MING-SHI;NATIONAL CHENG KUNG UNIVERSITY

发明人:

CHANG, MING-SHI

申请号：

EP13828706

公开号：

EP2882456A4

申请日:

2013.08.06

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/